格隆汇1月8日丨泰凌医药(01011.HK)公布,集团预期于截至2024年10月31日止十个月将录得公司拥有人应占亏损净额介乎人民币3500万元至人民币3700万元,而截至2023年10月31日止十个月则录得亏损净额约人民币1.53亿元。期间预期亏损净额减少乃主要由于:(a)于该期间并无录得生产及销售中成药业务("出售业务",该业务由公司前全资附属公司苏州第壹制药有限公司(已于2023年8月由集团...
Source Link格隆汇1月8日丨泰凌医药(01011.HK)公布,集团预期于截至2024年10月31日止十个月将录得公司拥有人应占亏损净额介乎人民币3500万元至人民币3700万元,而截至2023年10月31日止十个月则录得亏损净额约人民币1.53亿元。期间预期亏损净额减少乃主要由于:(a)于该期间并无录得生产及销售中成药业务("出售业务",该业务由公司前全资附属公司苏州第壹制药有限公司(已于2023年8月由集团...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.